Skip to main content
Erschienen in: World Journal of Urology 5/2020

14.09.2019 | Original Article

Day-surgery percutaneous nephrolithotomy: a high-volume center retrospective experience

verfasst von: Xiangkun Wu, Zhijian Zhao, Hongling Sun, Chao Cai, Zhilin Li, Donglong Cheng, Huacai Zhu, Guohua Zeng, Yongda Liu

Erschienen in: World Journal of Urology | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Percutaneous nephrolithotomy (PCNL) is traditionally performed on an inpatient basis. We determine the safety and outcome of day-surgery PCNL by experienced surgeon hands.

Patients and methods

A protocol for day-surgery PCNL was undertaken. A retrospective analysis of all 86 cases of planned day-surgery PCNL accomplished by an experienced surgeon who followed this protocol between May 2017 and March 2019 was performed. Patient demographics, operative data, complications, and readmission rates were recorded. Day-surgery PCNL was defined as discharge of patients either the same day or within 24 h after surgery.

Results

The average stone burden was 361.1 mm2 and 70 (81.4%) of patients had multiple stones or staghorn stones. 82 (95.4%) patients achieved same-day discharge or received overnight observation prior to discharge, and 4 patients (4.6%) required full admission (longer than 24 h). The readmission rate was 2.3% (2 patients). The postoperative complications occurred in 10 (11.6%) patients, including 7, 2, 2 of grade I, II, III complications. The average operation time was 64 min and the hemoglobin drop was 15.7 ± 16.9 g/L. The established tracts size ranged from 16 to 22Fr. The stone clearance rate was 90.7%. The tubeless without nephrostomy tube was performed in 60.5%. Eight cases were performed by multiple-tracts PCNL with 2–4 tracts, with only two case required full admission.

Conclusion

Experienced surgeons who performed day-surgery PCNL experience excellent patient outcomes in appropriately selected patients. Most complications can be treated conservatively and only a few required intervention or readmission.
Literatur
1.
Zurück zum Zitat Zeng G, Mai Z, Xia S et al (2017) Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 120:109–116CrossRef Zeng G, Mai Z, Xia S et al (2017) Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 120:109–116CrossRef
2.
Zurück zum Zitat Fernström I, Johansson B (1976) Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 10:257–259CrossRef Fernström I, Johansson B (1976) Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol 10:257–259CrossRef
3.
Zurück zum Zitat Ghani KR, Andonian S, Bultitude M et al (2016) Percutaneous nephrolithotomy: update, trends, and future directions. Eur Urol 70:382–396CrossRef Ghani KR, Andonian S, Bultitude M et al (2016) Percutaneous nephrolithotomy: update, trends, and future directions. Eur Urol 70:382–396CrossRef
4.
Zurück zum Zitat Zeng G, Wan S, Zhao Z et al (2016) Super-mini percutaneous nephrolithotomy (SMP): a new concept in technique and instrumentation. BJU Int 117:655–661CrossRef Zeng G, Wan S, Zhao Z et al (2016) Super-mini percutaneous nephrolithotomy (SMP): a new concept in technique and instrumentation. BJU Int 117:655–661CrossRef
5.
Zurück zum Zitat Nguyen D-D, Luo JW, Tailly T et al (2019) Percutaneous nephrolithotomy access: a systematic review of intraoperative assistive technologies. J Endourol 3(5):358–368CrossRef Nguyen D-D, Luo JW, Tailly T et al (2019) Percutaneous nephrolithotomy access: a systematic review of intraoperative assistive technologies. J Endourol 3(5):358–368CrossRef
6.
Zurück zum Zitat Seitz C, Desai M, Häcker A et al (2012) Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol 61:146–158CrossRef Seitz C, Desai M, Häcker A et al (2012) Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy. Eur Urol 61:146–158CrossRef
7.
Zurück zum Zitat Alyami F, Norman RW (2012) Is an overnight stay after percutaneous nephrolithotomy safe? Arab J Urol 10:367–371CrossRef Alyami F, Norman RW (2012) Is an overnight stay after percutaneous nephrolithotomy safe? Arab J Urol 10:367–371CrossRef
8.
Zurück zum Zitat Beiko D, Lee L (2010) Outpatient tubeless percutaneous nephrolithotomy: the initial case series. Can Urol Assoc J 4:E86–E90CrossRef Beiko D, Lee L (2010) Outpatient tubeless percutaneous nephrolithotomy: the initial case series. Can Urol Assoc J 4:E86–E90CrossRef
9.
Zurück zum Zitat Bechis SK, Han DS, Abbott JE et al (2018) Outpatient percutaneous nephrolithotomy: the UC San Diego health experience. J Endourol 32:394–401CrossRef Bechis SK, Han DS, Abbott JE et al (2018) Outpatient percutaneous nephrolithotomy: the UC San Diego health experience. J Endourol 32:394–401CrossRef
11.
Zurück zum Zitat Singh I, Kumar A, Kumar P (2005) “Ambulatory PCNL” (tubeless PCNL under regional anesthesia)—a preliminary report of 10 cases. Int Urol Nephrol 37:35–37CrossRef Singh I, Kumar A, Kumar P (2005) “Ambulatory PCNL” (tubeless PCNL under regional anesthesia)—a preliminary report of 10 cases. Int Urol Nephrol 37:35–37CrossRef
12.
Zurück zum Zitat Wu H, Wang Z, Zhu S et al (2018) Uroseptic shock can be reversed by early intervention based on leukocyte count 2 h post-operation: animal model and multicenter clinical cohort study. Inflammation 41:1835–1841CrossRef Wu H, Wang Z, Zhu S et al (2018) Uroseptic shock can be reversed by early intervention based on leukocyte count 2 h post-operation: animal model and multicenter clinical cohort study. Inflammation 41:1835–1841CrossRef
13.
Zurück zum Zitat Zhu W, Li J, Yuan J et al (2017) A prospective and randomised trial comparing fluoroscopic, total ultrasonographic, and combined guidance for renal access in mini-percutaneous nephrolithotomy. BJU Int 119:612–618CrossRef Zhu W, Li J, Yuan J et al (2017) A prospective and randomised trial comparing fluoroscopic, total ultrasonographic, and combined guidance for renal access in mini-percutaneous nephrolithotomy. BJU Int 119:612–618CrossRef
14.
Zurück zum Zitat Schoenfeld D, Zhou T, Stern JM (2019) Outcomes for patients undergoing ambulatory percutaneous nephrolithotomy. J Endourol 33:189–193CrossRef Schoenfeld D, Zhou T, Stern JM (2019) Outcomes for patients undergoing ambulatory percutaneous nephrolithotomy. J Endourol 33:189–193CrossRef
15.
Zurück zum Zitat El-Nahas AR, Elshal AM, El-Tabey NA et al (2016) Percutaneous nephrolithotomy for staghorn stones: a randomised trial comparing high-power holmium laser versus ultrasonic lithotripsy. BJU Int 118:307–312CrossRef El-Nahas AR, Elshal AM, El-Tabey NA et al (2016) Percutaneous nephrolithotomy for staghorn stones: a randomised trial comparing high-power holmium laser versus ultrasonic lithotripsy. BJU Int 118:307–312CrossRef
16.
Zurück zum Zitat Opondo D, Tefekli A, Esen T et al (2012) Impact of case volumes on the outcomes of percutaneous nephrolithotomy. Eur Urol 62:1181–1187CrossRef Opondo D, Tefekli A, Esen T et al (2012) Impact of case volumes on the outcomes of percutaneous nephrolithotomy. Eur Urol 62:1181–1187CrossRef
17.
Zurück zum Zitat Huang W-Y, Wu S-C, Chen Y-F et al (2014) Surgeon volume for percutaneous nephrolithotomy is associated with medical costs and length of hospital stay: a nationwide population-based study in Taiwan. J Endourol 28:915–921CrossRef Huang W-Y, Wu S-C, Chen Y-F et al (2014) Surgeon volume for percutaneous nephrolithotomy is associated with medical costs and length of hospital stay: a nationwide population-based study in Taiwan. J Endourol 28:915–921CrossRef
18.
Zurück zum Zitat Tepeler A, Karatag T, Tok A et al (2016) Factors affecting hospital readmission and rehospitalization following percutaneous nephrolithotomy. World J Urol 34:69–73CrossRef Tepeler A, Karatag T, Tok A et al (2016) Factors affecting hospital readmission and rehospitalization following percutaneous nephrolithotomy. World J Urol 34:69–73CrossRef
19.
Zurück zum Zitat Kreydin EI, Eisner BH (2013) Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol 10:598–605CrossRef Kreydin EI, Eisner BH (2013) Risk factors for sepsis after percutaneous renal stone surgery. Nat Rev Urol 10:598–605CrossRef
20.
Zurück zum Zitat Zheng J, Li Q, Fu W et al (2015) Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis 43:41–47CrossRef Zheng J, Li Q, Fu W et al (2015) Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis 43:41–47CrossRef
21.
Zurück zum Zitat Coley KC, Williams BA, DaPos SV et al (2002) Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth 14:349–353CrossRef Coley KC, Williams BA, DaPos SV et al (2002) Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anesth 14:349–353CrossRef
Metadaten
Titel
Day-surgery percutaneous nephrolithotomy: a high-volume center retrospective experience
verfasst von
Xiangkun Wu
Zhijian Zhao
Hongling Sun
Chao Cai
Zhilin Li
Donglong Cheng
Huacai Zhu
Guohua Zeng
Yongda Liu
Publikationsdatum
14.09.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 5/2020
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-019-02942-0

Weitere Artikel der Ausgabe 5/2020

World Journal of Urology 5/2020 Zur Ausgabe

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.